Catamaran Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 7

Catamaran Bio General Information

Description

Developer of allogeneic immune cell therapies designed to provide treatments for solid tumors and other cancers. The company engages in using genetic engineering of natural killer cells to target several therapeutic areas with high unmet needs, enabling medical practitioners and individuals to procure therapies for treating conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 451 D Street
  • Boston, MA 02210
  • United States
+1 (857)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 451 D Street
  • Boston, MA 02210
  • United States
+1 (857)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Catamaran Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Generating Revenue
2. Early Stage VC (Series A) 23-Nov-2020 Completed Generating Revenue
1. University Spin-Out 01-Jan-2020 Completed Startup
To view Catamaran Bio’s complete valuation and funding history, request access »

Catamaran Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A2
Series A1 54,285,708 $0.000100 8% $0.7 $0.7 1x $0.7 0%
To view Catamaran Bio’s complete cap table history, request access »

Catamaran Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of allogeneic immune cell therapies designed to provide treatments for solid tumors and other cancers. The com
Drug Discovery
Boston, MA
14 As of 2025

Waltham, MA
 

South San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Catamaran Bio Competitors (2)

One of Catamaran Bio’s 2 competitors is Dragonfly (Drug Discovery), a Venture Capital-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dragonfly (Drug Discovery) Venture Capital-Backed Waltham, MA
Nkarta Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 2 of 2 competitors. Get the full list »

Catamaran Bio Patents

Catamaran Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240156867-A1 Engineered immune cell therapeutics and methods of use Pending 11-Nov-2022
WO-2023172514-A1 Engineered immune cell therapeutics targeted to her2 and methods of use thereof Inactive 07-Mar-2022
AU-2021388155-A1 Cellular therapeutics engineered with signal modulators and methods of use thereof Pending 25-Nov-2020
EP-4251645-A1 Cellular therapeutics engineered with signal modulators and methods of use thereof Pending 25-Nov-2020
US-20220162288-A1 Cellular therapeutics engineered with signal modulators and methods of use thereof Inactive 25-Nov-2020 C07K14/70503
To view Catamaran Bio’s complete patent history, request access »

Catamaran Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Catamaran Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Astellas Venture Management Corporate Venture Capital Minority
Lightstone Ventures Venture Capital Minority
Sofinnova Partners Venture Capital Minority
SV Health Investors PE/Buyout Minority
Takeda Ventures Corporate Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Catamaran Bio FAQs

  • When was Catamaran Bio founded?

    Catamaran Bio was founded in 2020.

  • Where is Catamaran Bio headquartered?

    Catamaran Bio is headquartered in Boston, MA.

  • What is the size of Catamaran Bio?

    Catamaran Bio has 14 total employees.

  • What industry is Catamaran Bio in?

    Catamaran Bio’s primary industry is Drug Discovery.

  • Is Catamaran Bio a private or public company?

    Catamaran Bio is a Private company.

  • What is Catamaran Bio’s current revenue?

    The current revenue for Catamaran Bio is .

  • How much funding has Catamaran Bio raised over time?

    Catamaran Bio has raised $42M.

  • Who are Catamaran Bio’s investors?

    Astellas Venture Management, Lightstone Ventures, Sofinnova Partners, SV Health Investors, and Takeda Ventures are 5 of 7 investors who have invested in Catamaran Bio.

  • Who are Catamaran Bio’s competitors?

    Dragonfly (Drug Discovery) and Nkarta Therapeutics are competitors of Catamaran Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process